Cited 3 times in

Denosumab-related osteonecrosis of the jaw: a case report and management based on pharmacokinetics.

Title
Denosumab-related osteonecrosis of the jaw: a case report and management based on pharmacokinetics.
Authors
Tae min You;Kang-Hee Lee;Wonse Park;Soo-Hyeon Lee
Issue Date
2015
Journal Title
Oral Surgery Oral Medicine Oral Pathology Oral Radiology
ISSN
2212-4403
Citation
Oral Surgery Oral Medicine Oral Pathology Oral Radiology, Vol.120(5) : 548~553, 2015
Abstract
Denosumab, a monoclonal antibody against the receptor activator for nuclear factor-kappa B ligand (RANKL), is a recently approved antiresorptive drug that suppresses osteoclast formation by targeting preosteclasts, in contrast to the traditional antiresorptive bisphosphonates that target mature osteoclasts. Osteonecrosis of the jaw (ONJ) is a well-known, if rare, side effect of bisphosphonate therapy; however, cases of ONJ have also been reported since 2010 in patients taking denosumab. We describe here a patient who developed ONJ while receiving denosumab; the pharmacokinetics of denosumab and bisphosphonates are discussed in the context of ONJ management.
URI
http://www.sciencedirect.com/science/article/pii/S2212440315010962

http://ir.ymlib.yonsei.ac.kr/handle/22282913/141755
DOI
10.1016/j.oooo.2015.07.017.
Appears in Collections:
1. 연구논문 > 2. College of Dentistry > Dept. of Advanced General Dentistry
Yonsei Authors
사서에게 알리기
  feedback
Files in This Item:
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse